MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Cognitive reserve in non-demented patients with Parkinson’s disease might protect against amyloid burden effect on cognition

    B. Fernández-Rodríguez, R. Rodríguez-Rojas, P. Guida, C. Trompeta, D. Mata-Marín, I. Obeso-Martín, L. Vela, L. García-Cañamaque, JA. Obeso, C. Gasca-Salas (Móstoles, Spain)

    Objective: To evaluate the effect of cognitive reserve (CR) in patients with Parkinson’s disease (PD) without dementia. Background: CR concept is a principal factor explaining…
  • MDS Virtual Congress 2021

    Is cognitive performance related to motor performance among people with Parkinson disease?

    K. Rawson, L. Tueth, T. Baker, J. Cavanaugh, C. Colon-Semenza, T. Deangelis, D. Fulford, T. Nordahl, C. Thomas, M. Lavalley, M. Saint-Hilaire, J. Zajac, T. Ellis, G. Earhart (St. Louis, USA)

    Objective: To examine the relationship between cognitive and motor functioning among people with Parkinson disease (PD). Background: PD is a disabling, chronic condition affecting both…
  • MDS Virtual Congress 2021

    Providing Genetic Testing and Genetic Counseling to the Parkinson’s Disease Community: the PD GENEration Pilot Study Experience

    L. Cook, J. Verbrugge, J. Schulze, T. Schwantes-An, A. Chan, J. Beck, A. Naito, A. Hall, K. Marder, M. Nance, M. Schwarzschild, T. Simuni, A-M. Wills, R. Alcalay (Indianapolis, USA)

    Objective: A pilot study was conducted to assess the feasibility of offering widespread genetic testing and counseling to patients with Parkinson’s disease (PD) in the…
  • MDS Virtual Congress 2021

    Monogenic Portal of the Global Parkinson’s Genetics Program (GP2)

    SY. Lim, LM. Lange, H. Madoev, KR. Kumar, AH. Tan, M. Avenali, P. Heutink, EJ. Vollstedt, K. Lohmann, N. Mencacci, C. Klein, EM. Valente (Kuala Lumpur, Malaysia)

    Objective: To support the efforts of the Global Parkinson’s Genetics Program (GP2, http://gp2.org/) Monogenic Hub, by developing an easy-to-use online platform for case/family submission. Background:…
  • MDS Virtual Congress 2021

    Homozygous PRKN exon 3 deletion in an early-onset Parkinson’s disease family from the Kadazan-Dusun ethnic group indigenous to Sabah, Malaysia

    YW. Tay, JL. Lim, YK. Chia, AH. Tan, SY. Lim, A. Ahmad-Annuar (Kuala Lumpur, Malaysia)

    Objective: To determine the causal gene for early-onset Parkinson’s disease (PD) in a Malaysian family of Kadazan-Dusun ethnicity. Background: Among Asian populations, relatively little is…
  • MDS Virtual Congress 2021

    CHARACTERIZATION OF LRP10 EXPRESSION IN LEWY BODY DISORDERS AND IPSC-DERIVED BRAIN CELLS

    M. Grochowska, A. Carreras Mascaro, V. Boumeester, D. Natale, G. Breedveld, H. Geut, W. van Cappellen, A. Boon, A. Kievit, E. Sammler, P. Parchi, P. Cortelli, D. Alessi, W. V.D. Berg, V. Bonifati, W. Mandemakers (Rotterdam, Netherlands)

    Objective: Our objective is to characterize endogenous low-density lipoprotein-related protein 10 (LRP10) expression in human induced pluripotent stem cell (iPSC)-derived brain cell types, post-mortem brain…
  • MDS Virtual Congress 2021

    RNA Editing in Parkinson’s Disease Shows Changes in Mitochondrial and Manganese-Binding Pathways in Multiple Brain Regions

    A. Thele, O. Gardner, J. Vance, A. Griswold, J. Young, M. Pericak-Vance, W. Scott, E. Martin, W. Wang, D. Dykxhoorn, C. Petito, G. Beecham, D. Mash, S. Sivasankaran (Miami, USA)

    Objective: To identify RNA editing alterations associated with Parkinson’s disease (PD) in the Dorsal Motor Nucleus of the Vagus (DMV), Substantia Nigra (SN), and Cingulate…
  • MDS Virtual Congress 2021

    An Eyes-Open/Closed Manipulation Reveals Disrupted Default Mode Network Connectivity in Parkinson’s Disease and REM Sleep Behavior Disorder

    T. Ellmore, J. Suescun, S. Chandra, V. Thyne, M. Schiess (New York, USA)

    Objective: To spatially localize disruptions in default mode network connectivity in prodromal and diagnosed Parkinson’s disease relative to controls. Background: Previously our research team reported…
  • MDS Virtual Congress 2021

    Feasibility study of diffusion tensor imaging fiber tracking in PD patients after DBS operation

    Y. Li, C. Zhang, N. He, F. Yan, E. Haacke (Shanghai, China)

    Objective: To explore the feasible of depicting the nigrostriatal pathway (NSP), dentate rubro thalamic (DRTT) and hyperdirect pathway (HDP) for the postoperative PD patients with…
  • MDS Virtual Congress 2021

    The Influence of Affective Priming on the Speech Production Network in Parkinson’s Disease

    J. Schill, P. Sörös, K. Simonyan, C. Thiel, K. Witt (Oldenburg, Germany)

    Objective: Examine Parkinson’s disease (PD) related changes in the speech production network (SPN) and its reaction to emotional distraction. Background: PD can cause speech alterations…
  • « Previous Page
  • 1
  • …
  • 411
  • 412
  • 413
  • 414
  • 415
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley